Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Fidaxomicin and Fecal Microbiota Transplants for Severe Clostridium difficile Colitis

Mankal, Pavan Kumar, MD, MA1,*; Abed, Jean, MD1; Latte-Naor, Shelly, MD2; Grinspan, Ari, MD3; Kotler, Donald P., MD1

doi: 10.1097/MJT.0000000000000573
Therapeutic Challenges
Buy
SDC

1Division of Gastroenterology, Department of Medicine, Mount Sinai St. Luke's and Mount Sinai West Hospitals, Icahn School of Medicine, New York, NY;

2Division of Infectious Disease, Department of Medicine, Mount Sinai St. Luke's and Mount Sinai West Hospitals, Icahn School of Medicine, New York, NY; and

3Division of Gastroenterology, Department of Medicine, Mount Sinai Hospital, Icahn School of Medicine, New York, NY.

Address for correspondence: Division of Gastroenterology, Department of Medicine, Mount Sinai St Luke's and Mount Sinai West Hospitals, Icahn School of Medicine, S&R13, 1111 Amsterdam Avenue, New York, NY 10025. E-mail: jean.abed@mountsinai.org

The authors have no conflicts of interest to declare.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.